NCT05414461View on ClinicalTrials.gov

Efficacy of Combination Immunotherapy in Patients With Metastatic Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

March 10, 2019

Primary Completion Date

October 17, 2021

Study Completion Date

April 30, 2022

Conditions
Colorectal Cancer
Interventions
DRUG

Combinations

PD-1 inhibitor-based combinaiton treatment

Trial Locations (1)

310003

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors
lead

First Affiliated Hospital of Zhejiang University

OTHER

NCT05414461 - Efficacy of Combination Immunotherapy in Patients With Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter